Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12805328rdf:typepubmed:Citationlld:pubmed
pubmed-article:12805328lifeskim:mentionsumls-concept:C0042172lld:lifeskim
pubmed-article:12805328lifeskim:mentionsumls-concept:C0024623lld:lifeskim
pubmed-article:12805328lifeskim:mentionsumls-concept:C1749467lld:lifeskim
pubmed-article:12805328lifeskim:mentionsumls-concept:C0038952lld:lifeskim
pubmed-article:12805328lifeskim:mentionsumls-concept:C0085862lld:lifeskim
pubmed-article:12805328lifeskim:mentionsumls-concept:C1299583lld:lifeskim
pubmed-article:12805328lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:12805328lifeskim:mentionsumls-concept:C0443252lld:lifeskim
pubmed-article:12805328lifeskim:mentionsumls-concept:C1608386lld:lifeskim
pubmed-article:12805328lifeskim:mentionsumls-concept:C1549571lld:lifeskim
pubmed-article:12805328pubmed:issue12lld:pubmed
pubmed-article:12805328pubmed:dateCreated2003-6-13lld:pubmed
pubmed-article:12805328pubmed:abstractTextTo evaluate whether pretherapeutic serum soluble E-cadherin is an independent factor predicting long-term survival in gastric cancer. Gastric cancer remains the second leading cause of cancer-related deaths in the world, but a satisfactory tumor marker is currently unavailable for gastric cancer. Soluble E-cadherin has recently been found to have prognostic value in gastric cancer.lld:pubmed
pubmed-article:12805328pubmed:languageenglld:pubmed
pubmed-article:12805328pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12805328pubmed:citationSubsetIMlld:pubmed
pubmed-article:12805328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12805328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12805328pubmed:statusMEDLINElld:pubmed
pubmed-article:12805328pubmed:monthJunlld:pubmed
pubmed-article:12805328pubmed:issn0732-183Xlld:pubmed
pubmed-article:12805328pubmed:authorpubmed-author:ChanAnnie...lld:pubmed
pubmed-article:12805328pubmed:authorpubmed-author:WongJohnJlld:pubmed
pubmed-article:12805328pubmed:authorpubmed-author:WongBenjamin...lld:pubmed
pubmed-article:12805328pubmed:authorpubmed-author:LawSimonSlld:pubmed
pubmed-article:12805328pubmed:authorpubmed-author:LamShiu-KumSKlld:pubmed
pubmed-article:12805328pubmed:authorpubmed-author:ChuKent-ManKMlld:pubmed
pubmed-article:12805328pubmed:authorpubmed-author:HuiWai-MoWMlld:pubmed
pubmed-article:12805328pubmed:authorpubmed-author:KwokKa-FaiKFlld:pubmed
pubmed-article:12805328pubmed:authorpubmed-author:KoSamuelSlld:pubmed
pubmed-article:12805328pubmed:authorpubmed-author:YuengYui-Hung...lld:pubmed
pubmed-article:12805328pubmed:issnTypePrintlld:pubmed
pubmed-article:12805328pubmed:day15lld:pubmed
pubmed-article:12805328pubmed:volume21lld:pubmed
pubmed-article:12805328pubmed:ownerNLMlld:pubmed
pubmed-article:12805328pubmed:authorsCompleteYlld:pubmed
pubmed-article:12805328pubmed:pagination2288-93lld:pubmed
pubmed-article:12805328pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12805328pubmed:meshHeadingpubmed-meshheading:12805328...lld:pubmed
pubmed-article:12805328pubmed:meshHeadingpubmed-meshheading:12805328...lld:pubmed
pubmed-article:12805328pubmed:meshHeadingpubmed-meshheading:12805328...lld:pubmed
pubmed-article:12805328pubmed:meshHeadingpubmed-meshheading:12805328...lld:pubmed
pubmed-article:12805328pubmed:meshHeadingpubmed-meshheading:12805328...lld:pubmed
pubmed-article:12805328pubmed:meshHeadingpubmed-meshheading:12805328...lld:pubmed
pubmed-article:12805328pubmed:meshHeadingpubmed-meshheading:12805328...lld:pubmed
pubmed-article:12805328pubmed:meshHeadingpubmed-meshheading:12805328...lld:pubmed
pubmed-article:12805328pubmed:meshHeadingpubmed-meshheading:12805328...lld:pubmed
pubmed-article:12805328pubmed:meshHeadingpubmed-meshheading:12805328...lld:pubmed
pubmed-article:12805328pubmed:meshHeadingpubmed-meshheading:12805328...lld:pubmed
pubmed-article:12805328pubmed:meshHeadingpubmed-meshheading:12805328...lld:pubmed
pubmed-article:12805328pubmed:meshHeadingpubmed-meshheading:12805328...lld:pubmed
pubmed-article:12805328pubmed:meshHeadingpubmed-meshheading:12805328...lld:pubmed
pubmed-article:12805328pubmed:meshHeadingpubmed-meshheading:12805328...lld:pubmed
pubmed-article:12805328pubmed:meshHeadingpubmed-meshheading:12805328...lld:pubmed
pubmed-article:12805328pubmed:meshHeadingpubmed-meshheading:12805328...lld:pubmed
pubmed-article:12805328pubmed:meshHeadingpubmed-meshheading:12805328...lld:pubmed
pubmed-article:12805328pubmed:meshHeadingpubmed-meshheading:12805328...lld:pubmed
pubmed-article:12805328pubmed:year2003lld:pubmed
pubmed-article:12805328pubmed:articleTitleSoluble E-cadherin is an independent pretherapeutic factor for long-term survival in gastric cancer.lld:pubmed
pubmed-article:12805328pubmed:affiliationDepartment of Medicine, University of Hong Kong Medical Center, Queen Mary Hospital, Pokfulam, Hong Kong, China.lld:pubmed
pubmed-article:12805328pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12805328pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12805328lld:pubmed